QLC5508 in Advanced Solid Tumors:: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction

Clinical trial NCT07620041 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07620041
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory or Relapsed Solid Tumors

Start date: 2026-06-05
Primary completion: 2026-12-05
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.